Dr. Bhavna Chawla [C08835] – New Delhi
India has the largest number of Retinoblastoma (RB) cases in the world. Although a potentially fatal cancer, management of RB has witnessed major advances in recent times, with an increasing trend towards globe salvage & vision preservation. Newer local routes of drug delivery like intra-arterial & intra-vitreal chemotherapy have shown success. Enucleation serves as a life-saving intervention in advanced cases & the importance of post-operative adjuvant therapy has been recognized. In orbital RB, a multi-modal treatment approach has improved survival outcomes. Genetic testing & counselling is emerging as an important aspect of management. This IC aims to provide a comprehensive overview of recent advances in RB. Difficult & challenging case scenarios will be highlighted & audience interaction will be encouraged. At the end of the course, the participants will become familiar with newer therapeutic modalities for RB and will be able to takemanagement-related decisions with confidence.
| 1 | What’s new in the Classification & Staging of Retinoblastoma? (10 mins) | Dr. Vikas Khetan |
| 2 | Intra-arterial and Intra-vitreal Chemotherapy: Lessons learnt (10 mins) | Dr. Bhavna Chawla |
| 3 | Enucleation & Rehabilitation of the Anophthalmic Socket (10 mins) | Dr. Kasturi Bhattacharjee |
| 4 | Post-operative Adjuvant therapy: What, when, how? (10 mins) | Dr. Swathi Kaliki |
| 5 | Orbital Retinoblastoma: The Multi-modal Approach (10 mins) | Dr. Santosh G Honavar |
| 6 | Advances in Genetic Testing & Counselling (10 mins) | Prof.G Kumaramanickavel |
| 7 | Challenging case scenarios (8 mins) | Dr. Bhavna Chawla |
| Panel Discussion : (7 mins.) |